Institut Pasteur Korea – Genexine Sign MOU for Global Clinical Trials for the COVID-19 Vaccine

Apr 12, 2021admin

Genexine and KG Bio agree to sign License agreement for Genexine’s novel immuno-oncology drug GX-I7

Feb 18, 2021admin

Genexine and NeoImmuneTech Announce Data Release for their Phase 1/2 Study of GX-I7/NT-I7 (efineptakin alfa) and KEYTRUDA® (pembrolizumab) in patients with Triple-Negative Breast Cancer

Nov 9, 2020admin

2020 KOSDAQ Global IR Conference

Oct 14, 2020admin

Korean Covid-19 vaccine, treatment candidates effective in monkeys

Aug 20, 2020admin